du-21220 has been researched along with Hyperthyroidism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cokkinos, DV; Karageorgiou, H; Kostopanagiotou, G; Mourouzis, I; Mourouzis, K; Pantos, C; Pappas, M; Tesseromatis, C | 1 |
1 other study(ies) available for du-21220 and Hyperthyroidism
| Article | Year |
|---|---|
Thyroid hormone modulates the responsiveness of rat aorta to alpha1-adrenergic stimulation: an effect due to increased activation of beta2-adrenergic signaling.
Topics: Acetylcholine; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Aorta, Thoracic; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperthyroidism; Male; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred WKY; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-2; Ritodrine; Signal Transduction; Thyroxine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2009 |